1. P-148Nimotuzumab bi-weekly/low dose combined to chemotherapy in advanced pancreatic cancer: A clinical study. (20th June 2018) Authors: Lima, M; Jennifer, V; Dominguez, C; Robin, G; Dunia, M; Alexander, O; Giselle, G; Amparo, M; Ivan, R; Noyde, B; Soriano, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗